Back to Search
Start Over
AFLIBERCEPT FOR DIABETIC MACULAR EDEMA: SEEING DOLLAR SIGNS: Level 3 [lacking direct] evidence
- Source :
- Clinical Advisor. March 2020, Vol. 23 Issue 1, p11, 1 p.
- Publication Year :
- 2020
-
Abstract
- Aflibercept is a vascular endothelial growth factor (VEGF) inhibitor first approved for treatment of diabetic macular edema (DME) in July 2014 after several large trials showed it was superior to [...]
Details
- Language :
- English
- ISSN :
- 15247317
- Volume :
- 23
- Issue :
- 1
- Database :
- Gale General OneFile
- Journal :
- Clinical Advisor
- Publication Type :
- Periodical
- Accession number :
- edsgcl.619012138